On the evening of June 16, 2022, an exceptionally bright and warm day, OHE hosted a party to celebrate the 60th anniversary of its existence. The event took place at 4 Hamilton Place, an Edwardian Mansion in the heart of Mayfair, London. About 140 attendants were served nibbles...
As the OHE continues to expand, we have another opportunity to welcome economists at a junior level to our team of talented researchers. Our team get the opportunity to work on a wide variety of policy-relevant projects across the health and life sciences...
As Professor Mike Drummond and Professor Bengt Jonnson step down from the OHE Board of Trustees after more than a decade of service, OHE announces the appointment of Professor Margaret Kyle and Professor Werner Brouwer as replacements with Professor Anita Charlesworth becoming chair
As a Charity, OHE is governed by a Board of Trustees which today is comprised of a mixture of academic and industry experts. OHE has been privileged to have many leading health economists serving on its Boards and Committees over the nearly 60 years of its existence.
In the 2017 Industrial Strategy, the Government committed to increasing investment in UK Research and Development to the OECD-average of 2.4% of Gross Domestic Product (GDP) by 2027, with a longer-term goal of reaching 3% to put the UK in the upper quartile. Whilst there is universal agreement that increasing R&D investment in the UK is a worthy goal, there is an ongoing discussion over how best to achieve it.
The Office of Health Economics wishes to recruit a well-qualified, highly motivated and energetic economist with an industrial organisation background applied to the health care sector, health care systems and/or the life sciences industry.
‘Cascades of care’ have emerged as an attractive tool for assessing access to care for numerous chronic diseases. Dr Haacker will examine the use of cascades of care across diseases and populations, evaluate the use of cross-sectional targets in disease control strategies (e.g., the UNAIDS 90-90-90 targets), and address implications for cost-effectiveness analysis.